Even though the physiological role of serum/plasma soluble CD26 (sCD26) protein with dipeptidyl peptidase 4 (DPP4, EC 3.4.14.5) activity as a ligand remains unclear (several possibilities have been reported in recent years), increasing evidence suggest that it can work as a biomarker in cancer. The gene discussed is DPP4; the disease is cancer.